Fifty 1 Labs, Inc.
Consumer Automotive Finance Inc. operates as a retailer in the used vehicle market of the United States. It focuses primarily on the buy here/pay here segment of the independent used vehicle sales and finance market. The company sells approximately 2000 and newer model-year used vehicles and provides related financing through sale type leases. As of December 31, 2010, it had two retail locations … Read more
Fifty 1 Labs, Inc. (FITY) - Net Assets
Latest net assets as of March 2024: $-146.94K USD
Based on the latest financial reports, Fifty 1 Labs, Inc. (FITY) has net assets worth $-146.94K USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($27.55K) and total liabilities ($174.48K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-146.94K |
| % of Total Assets | -533.44% |
| Annual Growth Rate | N/A |
| 5-Year Change | -81461.9% |
| 10-Year Change | N/A |
| Growth Volatility | 26237.56 |
Fifty 1 Labs, Inc. - Net Assets Trend (2005–2024)
This chart illustrates how Fifty 1 Labs, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Fifty 1 Labs, Inc. (2005–2024)
The table below shows the annual net assets of Fifty 1 Labs, Inc. from 2005 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | $-119.60K | +25.24% |
| 2023-06-30 | $-159.99K | +1.23% |
| 2022-06-30 | $-161.99K | -67.50% |
| 2021-06-30 | $-96.71K | -65886.39% |
| 2020-06-30 | $147.00 | +100.25% |
| 2019-06-30 | $-59.73K | -326.16% |
| 2018-06-30 | $26.41K | +100.31% |
| 2010-06-30 | $-8.41 Million | -29.06% |
| 2009-06-30 | $-6.52 Million | -333.24% |
| 2008-06-30 | $-1.50 Million | -787.82% |
| 2007-06-30 | $218.75K | -91.27% |
| 2006-06-30 | $2.51 Million | +20.60% |
| 2005-06-30 | $2.08 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Fifty 1 Labs, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 585675800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $762.98K | % |
| Other Components | $4.99 Million | % |
| Total Equity | $-119.60K | 100.00% |
Fifty 1 Labs, Inc. Competitors by Market Cap
The table below lists competitors of Fifty 1 Labs, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
All American Gld Crp
PINK:AAGC
|
$8.97 |
|
Winners Inc
PINK:WNRS
|
$9.04 |
|
Emergent Health Corp
PINK:EMGE
|
$9.14 |
|
NUWEW
PINK:NUWEW
|
$9.19 |
|
Gemini Group Global Corp
PINK:GMNI
|
$8.87 |
|
Consolidated Capital of North America Inc
PINK:CDNO
|
$8.78 |
|
Bliss-Tel PLC
BK:BLISS
|
$8.77 |
|
Consumer Automotive Finance Inc
PINK:CAFI
|
$8.76 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fifty 1 Labs, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -159,986 to -119,602, a change of 40,384.
- Net loss of 1,248 reduced equity.
- Other comprehensive income increased equity by 159,986.
- Other factors decreased equity by 118,354.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.25K | -1.04% |
| Other Comprehensive Income | $159.99K | +133.77% |
| Other Changes | $-118.35K | -98.96% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Fifty 1 Labs, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-06-30 | $0.00 | $0.00 | x |
| 2005-06-30 | $0.31 | $0.00 | x |
| 2006-06-30 | $0.28 | $0.00 | x |
| 2007-06-30 | $0.02 | $0.00 | x |
| 2008-06-30 | $-0.15 | $0.00 | x |
| 2009-06-30 | $-0.69 | $0.00 | x |
| 2010-06-30 | $-0.90 | $0.00 | x |
| 2018-06-30 | $0.00 | $0.00 | x |
| 2019-06-30 | $0.00 | $0.00 | x |
| 2020-06-30 | $0.00 | $0.00 | x |
| 2021-06-30 | $0.00 | $0.00 | x |
| 2022-06-30 | $0.00 | $0.00 | x |
| 2023-06-30 | $0.00 | $0.00 | x |
| 2024-06-30 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fifty 1 Labs, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1733.33%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-1798.18%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | -281.97% | 0.00% | 0.00x | 1.00x | $-7.64K |
| 2005 | -0.64% | -133.68% | 0.00x | 1.33x | $-221.10K |
| 2006 | -17.85% | -3.83% | 1.95x | 2.39x | $-697.78K |
| 2007 | -1045.20% | -32.93% | 1.01x | 31.48x | $-2.31 Million |
| 2008 | 0.00% | -38.16% | 0.59x | 0.00x | $-1.57 Million |
| 2009 | 0.00% | -41.24% | 1.40x | 0.00x | $-1.58 Million |
| 2010 | 0.00% | -37.10% | 1.18x | 0.00x | $-1.05 Million |
| 2018 | -13.00% | -13.31% | 1.02x | 0.95x | $-30.91K |
| 2019 | -115.10% | -501.40% | 0.36x | 0.64x | $-121.56K |
| 2020 | -23700.68% | -211.15% | 0.15x | 748.68x | $-34.85K |
| 2021 | 0.00% | -58.34% | 1.10x | 0.00x | $-33.43K |
| 2022 | 0.00% | 81.60% | 0.69x | 0.00x | $30.89K |
| 2023 | 0.00% | -550.42% | 3.54x | 0.00x | $-491.03K |
| 2024 | 0.00% | -1733.33% | 0.00x | 0.00x | $10.71K |
Industry Comparison
This section compares Fifty 1 Labs, Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fifty 1 Labs, Inc. (FITY) | $-146.94K | -281.97% | N/A | $8.95 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |